Carl Borrebaeck

Member of the Board of Directors since 2017

Education: DSc

Background: Professor Lund University. Co-founder of Immunovia AB, Senzagen AB, BioInvent International AB, Alligator Bioscience AB.

Other ongoing assignments: Chairman of the Board in Immunovia AB, SenzaGen AB and PainDrainer AB. Board member in PainDrainer AB

Independence: Independent in relation to both the Company and executive management as well as larger shareholders

Scandion Oncology shares and warrants
112,165 shares and 26,792 warrants (partly owned via CB Ocean Capital AB)